Skip to content

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

  • Authors

    • Dr. Christian Schmidl

    • Dr. Christian Schmidl

  • Date Published

    August 30, 2019

Schmidl C*, Vladimer GI*, Rendeiro AF*, Schnabl S*, Krausgruber T, Taubert C, Krall N, Pemovska T, Araghi M, Snijder B, Hubmann R, Ringler A, Runggatscher K, Demirtas D, de la Fuente OL, Hilgarth M, Skrabs C, Porpaczy E, Gruber M, Hoermann G, Kubicek S, Staber PB, Shehata M, Superti-Furga G, Jager U et al. Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL. Nat Chem Biol. 2019 Mar. 15:232-240. doi:10.1038/s41589-018-0205-2. PMID: 30692684